Published in Mod Pathol on January 03, 2014
Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis (2014) 0.98
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol (2014) 0.93
Melanoma epigenetics: novel mechanisms, markers, and medicines. Lab Invest (2014) 0.89
The role of 5-hydroxymethylcytosine in human cancer. Cell Tissue Res (2014) 0.81
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features. Pigment Cell Melanoma Res (2014) 0.81
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations. J Cutan Pathol (2015) 0.81
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget (2015) 0.79
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies. PLoS One (2016) 0.79
Sex-Specific Associations of Arsenic Exposure with Global DNA Methylation and Hydroxymethylation in Leukocytes: Results from Two Studies in Bangladesh. Cancer Epidemiol Biomarkers Prev (2015) 0.79
5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas. Sci Rep (2016) 0.76
Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update. Dermatopathology (Basel) (2015) 0.75
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma. Mod Pathol (2016) 0.75
Ascorbate induces apoptosis in melanoma cells by suppressing Clusterin expression. Sci Rep (2017) 0.75
Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Oncotarget (2016) 0.75
TET2 Negatively Regulates Nestin Expression in Human Melanoma. Am J Pathol (2016) 0.75
Epigenetic Modifications and Accumulation of DNA Double-Strand Breaks in Oral Lichen Planus Lesions Presenting Poor Response to Therapy. Medicine (Baltimore) (2015) 0.75
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science (2009) 32.97
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell (2011) 4.89
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene (2012) 2.82
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget (2011) 2.80
Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms? Arch Pathol Lab Med (2011) 2.60
Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development (2012) 2.24
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci (2012) 1.79
Image and statistical analysis of melanocytic histology. Histopathology (2012) 1.16
Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia. Leukemia (2011) 1.12
Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. Arch Pathol Lab Med (2010) 1.10
Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR). Am J Surg Pathol (2013) 0.91
Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. Hum Pathol (1999) 0.82
Differentiation between malignant melanomas and benign melanocytic nevi by computerized DNA cytometry of imprint specimens. J Cutan Pathol (1994) 0.80
Histopathologic spectrum of hypersensitivity reactions associated with anti-CD52 therapy (alemtuzumab). J Cutan Pathol (2016) 1.39
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol (2014) 0.93
Melanoma epigenetics: novel mechanisms, markers, and medicines. Lab Invest (2014) 0.89
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget (2015) 0.79
Preventing Scars after Injury with Partial Irreversible Electroporation. J Invest Dermatol (2016) 0.75